Claims
- 1. A biocompatible hydrogel polymer comprising a methacrylate functional sulfoxide, sulfide or sulfone monomer copolymerized with a hydrophilic or hydrophobic matrix copolymerizing material selected from the group consisting of an acrylamide, methacrylamide, acrylate, methacrylate, siloxane, vinyl and a derivative thereof, present in concentration from about 1 to about 99 wt %.
- 2. The hydrogel of claim 1 wherein the copolymerizing material is the derivative N-vinyl-pyrrolidone, hydroxyethyl methacrylate, methyl methacrylate, methacrylic acid, glycerol methacrylate, 1,2-dihydroxypropyl methacrylate or N,N,dimethyl acrylamide.
- 3. The hydrogel of claim 2 wherein the copolymerizing material is hydroxyethyl methacrylate copolymerized with methacrylate functional sulfoxide monomer present in concentration from about 1 to about 99 wt %.
- 4. The hydrogel of claim 3 wherein the functional sulfoxide monomer is present in concentration from about 5 to about 40 wt %.
- 5. The hydrogel of claim 2 wherein the copolymerizing material is hydroxyethyl methacrylate copolymerized with methacrylate functional sulfide monomer present in concentration from about 1 to about 99 wt %.
- 6. The hydrogel of claim 5 wherein the functional sulfide monomer is present in concentration from about 5 to about 40 wt %.
- 7. The hydrogel of claim 2 wherein the copolymerizing material is hydroxyethyl methacrylate copolymerized with methacrylate functional sulfone monomer present in concentration from about 1 to about 99 wt %.
- 8. The hydrogel of claim 7 wherein the functional sulfone monomer is present in concentration from about 5 to about 40 wt %.
- 9. A biocompatible hydrogel implant material for fabrication of medical implants or contact lenses, said material comprising from about 5 to about 50 wt % of a methacrylate functional sulfoxide, sulfide or sulfone monomer copolymerized with a hydrophilic or hydrophobic copolymerizing material selected from the group consisting of an acrylamide, methacrylamide, acrylate, methacrylate, siloxane, vinyl and a derivative thereof present in concentration from about 1 to about 99 wt %.
- 10. The hydrogel of claim 2 wherein the methacrylate-functional monomer has a formula ##STR13## compound 23, namely methyl 3-(acryloyloxy)propyl sulfoxide.
- 11. The hydrogel of claim 2 wherein the methacrylate-functional monomer has a formula ##STR14## compound 24, namely methyl 3-(acryloyloxy)di(propyl sulfoxide).
- 12. The hydrogel of claim 2 wherein the methacrylate-functional monomer has a formula ##STR15## compound 18, namely 3-methylthio-1-propyl acrylate.
- 13. The hydrogel of claim 2 wherein the methacrylate-functional monomer has a formula ##STR16## compound 26, namely methyl 3-(acryloyloxy)propyl sulfone.
- 14. The hydrogel of claim 9 wherein the methacrylate-functional monomer has a formula ##STR17## compound 23, namely methyl 3-(acryloyloxy)propyl sulfoxide.
- 15. The hydrogel of claim 9 wherein the methacrylate-functional sulfoxide monomer has a formula ##STR18## compound 24, namely methyl 3-(acryloyloxy)di(propyl sulfoxide).
- 16. The hydrogel of claim 9 wherein the methacrylate-functional sulfide monomer has a formula ##STR19## compound 18, namely 3-methylthio-1-propyl acrylate.
- 17. The hydrogel of claim 9 wherein the methacrylate-functional sulfone monomer has a formula ##STR20## compound 26, namely methyl 3-(acryloyloxy)propyl sulfone.
Parent Case Info
This application claims the benefit of U.S. Provisional No. 60/057,444 filed Sep. 3, 1997.
Government Interests
The United States Government has certain rights in this invention pursuant to Contract DE-AC03-76SF00098 between the United States Department of Energy and the University of California.
US Referenced Citations (10)
Foreign Referenced Citations (1)
Number |
Date |
Country |
0231 572 A2 |
Dec 1987 |
EPX |